ArticleClinical pharmacology and therapeutics2025

Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHL.

Candice Jamois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.